E2 ModerateModerate confidencePEM not requiredObservationalPeer-reviewedReviewed
Standard · 3 min
Epidemiology of chronic fatigue syndrome: the Centers for Disease Control Study.
Gunn, W J, Connell, D B, Randall, B · Ciba Foundation symposium · 1993 · DOI
Quick Summary
Between 1989 and 1991, the CDC tracked patients with chronic fatigue syndrome across four U.S. cities to understand how common the illness is and who gets it. Researchers found that only about 1 in 4 patients referred to them actually met the strict diagnostic criteria for CFS, while others had different medical conditions or psychiatric histories that might explain their fatigue. The study estimated that CFS affects roughly 2–11 people per 100,000 in the general population, and it most commonly affected women in their 30s.
Why It Matters
This is one of the earliest CDC-led epidemiological studies to systematically define and quantify CFS prevalence in the U.S., establishing the foundation for case definitions and surveillance methods used in subsequent research. It highlights the challenge of distinguishing CFS from other medical and psychiatric conditions, which remains clinically relevant today. The demographic findings—particularly the female predominance—have shaped understanding of CFS risk patterns for three decades.
Observed Findings
Only 26% of 337 patients reviewed met full CFS case definition criteria.
45% of referred patients had psychiatric disorder histories preceding fatigue onset and were excluded from CFS classification.
15% of referred patients had alternative medical illnesses that could account for severe fatigue.
Minimum prevalence ranged from 2.0–7.3 per 100,000 across four study sites; prorated estimates ranged from 4.6–11.3 per 100,000.
Over 80% of confirmed CFS cases were female, mostly white, with average age at symptom onset approximately 30 years.
Inferred Conclusions
CFS is a distinct illness separable from psychiatric disorders when careful diagnostic screening is applied, though a significant minority of fatigued patients have comorbid or pre-existing psychiatric conditions.
The prevalence of CFS in the U.S. is measurable but relatively low (several cases per 100,000), consistent across geographically diverse sites.
CFS affects predominantly women and typically begins in early adulthood.
Remaining Questions
Does the exclusion of patients with pre-existing psychiatric illness accurately reflect CFS biology, or does it artificially narrow the case definition and exclude patients with both conditions?
What This Study Does Not Prove
This study does not prove that psychiatric disorders cause CFS; the exclusion of patients with pre-existing psychiatric illness does not demonstrate causation in those who developed CFS afterward. The cross-sectional design cannot establish incidence or natural history of the illness. Prevalence estimates are based on referral patterns to participating physicians, which may not represent the true population burden of CFS.
About the PEM badge: “PEM required” means post-exertional malaise was an explicit required diagnostic criterion for participant inclusion in this study — not that PEM was studied, observed, or discussed. Studies using criteria that do not require PEM (e.g. Fukuda, Oxford) are tagged “PEM not required”. How the atlas works →
Contribute
Private, reviewed by a human. Not a public comment thread.
Why is the female-to-male ratio so skewed, and what biological or behavioral factors drive sex differences in CFS incidence?
How do prevalence estimates differ when using alternative case definitions or when screening the general population rather than relying on physician referrals?
What is the natural history and long-term course of CFS in this cohort?